Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease

Southern Medical Journal

Volumn 101, Issue 9, 2008, Pages 900-905

  Tsai, Chung Huang ^a   Li, Tsai Chung ^b   Lin, Cheng Chieh ^b  

^a CHENG CHING GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Screening health examination; Waist circumference

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL EXAMINATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; BODY MASS; FATTY LIVER; INSULIN RESISTANCE; MIDDLE AGED; PREVALENCE; STATISTICAL MODEL; TAIWAN;

ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; TAIWAN;

EID: 53449102536     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31817e8af9     Document Type: Article

References (37)

1. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine 1962;41:249-276.
2. Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006;91:4753-4761.
3. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998;114:842-845.
4. Ludwig J, Viaggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: mayo clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.
5. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histological comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-1062.
6. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-598.
7. Lonardo A, Bellini M, Tartoni P, et al. The bright liver syndrome: prevalence and determinants of a 'bright' liver echopattern. Ital J Gastroenterol Hepatol 1997;29:351-356.
8. Araujo LM, De Oliveira DA, Nunes DS. Liver and biliary ultrasonography in diabetic and non-diabetic obese women. Diabetes Metab 1998; 24:458-462.
9. Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
10. el-Hassan AY, Ibrahim EM, al-Mulhim FA, et al. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992;65:774-778.
11. Nomura H, Kashiwagi S, Hayashi J, et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-149.
12. Bloomgarden ZT. Second World Congress on the insulin resistance syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease. Diabetes Care 2005;28:1518-1523.
13. Younossi ZM. Nonalcoholic fatty liver disease. Curr Gastroenterol Rep 1999;1:57-62.
14. Fletcher B, Lamendola C. Insulin resistance syndrome. J Cardiovasc Nurs 2004;19:339-345.
15. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. N ature 2001;414:782-787.
16. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-29F.
17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
18. Hoefner DM. The ruthless malady:metabolic syndrome. MLO Med Lab Obs 2003;35:12-21.
19. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the insulin resistance atherosclerosis study. Diabetes 1997;46:63-69.
20. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
22. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107: 450-455.
23. Pegano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002;35:367-372.
24. Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003;285:E906-E916.
25. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in nondiabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005;48:634-642.
26. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-1186.
27. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National health and nutrition examination survey. JAMA 2002;287:356-359.
28. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-689.
29. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33:351-375.
30. Chuang SY, Chen CH, Tsai ST, et al. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002;18:16-23.
31. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
32. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12: 1106-1110.
33. Bacon BR, Farahvash AU, Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109.
34. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143:722-728.
35. Medina J, Fernandez-Salazar LI, Garcia-Buey L, et al. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004;27:2057-2066.
36. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996;24:25-29.
37. Caturelli E, Squillante MM, Andriulli A, et al. Hypoechoic lesions in the "bright liver": a reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol 1992;7:469-472.